X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

HSR Thresholds Will Increase for 2020 Transactions

Size-of-transaction threshold under Hart-Scott-Rodino Act will increase to $94 million. On February...

Read More >

From The Jetsons to Reality, or Almost: What Employers Need to Know About Robots and AI in the Workplace

Many readers will remember The Jetsons – a futuristic world in which sophisticated robots in both t...

Read More >

Financial institutions M&A: Sector trends - February 2020: Specialty Finance/Marketplace Lending

Financial institutions M&A sector trends: specialty finance/marketplace lending — H2 2019 and outlo...

Read More >

Exploring H-1B Dependency for Employers

With the increasing reliance of U.S. employers on high-skilled foreign workers, particularly those o...

Read More >

COVID-19 UK: Permitted development rights to help take away the strain

The UK government’s actions are ramping up as it battles to contain the spread of COVID-19 and enfo...

Read More >

U.K. Competition & Markets Authority Publishes Important Brexit Guidance

In anticipation of the United Kingdom’s exit from the EU on December 31 (‘Brexit’), the Competiti...

Read More >